Lataa...
Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity a...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3206123/ https://ncbi.nlm.nih.gov/pubmed/22069354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S23698 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|